Showing results (141-150 of 463) with videos related to

Sort By:
Pageof 47
Clinical Chemistry|September 10, 2011
A new functional CYP3A4 intron 6 polymorphism significantly affects tacrolimus pharmacokinetics in kidney transplant recipientsLaure Elens, Rachida Bouamar, Dennis A Hesselink, et al.
Therapeutic Drug Monitoring|June 8, 2013
Genetic polymorphisms in ABCB1 influence the pharmacodynamics of tacrolimusRamin Vafadari, Rachida Bouamar, Dennis A Hesselink, et al.
Annals of Translational Medicine|June 30, 2018
No association between systemic complement activation and intensive care unit-acquired weaknessEsther Witteveen, Luuk Wieske, Friso M de Beer, et al.
Clinical Endocrinology|November 24, 2006
Expression of activin and inhibin subunits, receptors and binding proteins in human adrenocortical neoplasmsJ Hofland, M A Timmerman, W W de Herder, et al.
HIV Medicine|November 23, 2011
Incentivized recruitment of a population sample to a mobile HIV testing service increases the yield of newly diagnosed cases, including those in need of antiretroviral therapyK Kranzer, D Govindasamy, N van Schaik, et al.
Muscle & Nerve|May 28, 2015
Assessment of intensive care unit-acquired weakness in young and old mice: An E. coli septic peritonitis modelEsther Witteveen, Inge C M Hoogland, Luuk Wieske, et al.
Annals of Intensive Care|April 7, 2017
Diagnostic accuracy of quantitative neuromuscular ultrasound for the diagnosis of intensive care unit-acquired weakness: a cross-sectional observational studyEsther Witteveen, Juultje Sommers, Luuk Wieske, et al.
Journal of the Peripheral Nervous System : JPNS|January 18, 2018
Elevated leukocyte count in cerebrospinal fluid of patients with chronic inflammatory demyelinating polyneuropathyIlse M Lucke, Stojan Peric, Gwen G A van Lieverloo, et al.
Pharmacogenetics and Genomics|August 4, 2010
Polymorphisms in type I and II inosine monophosphate dehydrogenase genes and association with clinical outcome in patients on mycophenolate mofetilOlivier Gensburger, Ron H N Van Schaik, Nicolas Picard, et al.
British Journal of Clinical Pharmacology|June 14, 2019
Differences in CYP3A genotypes of a liver transplant recipient and the donor liver graft and adjustment of tacrolimus doseFlorine A Berger, Midas B Mulder, Willemijn Ten Bosch-Dijksman, et al.
Pageof 47